Home » Topics » BioWorld Science

BioWorld Science
RSS

New Janus kinase inhibitors synthesized at Leo Pharma

Aug. 14, 2018

Council of Scientific and Industrial Research divulges caerulomycin A analogues

Aug. 14, 2018

Mustang Bio, St. Jude's Children's Research Hospital to develop gene therapy for X-SCID

Aug. 14, 2018

Liverpool School of Tropical Medicine and collaborators patent compounds for filariasis

Aug. 14, 2018

FDA issues complete response letter regarding the sBLA for Eylea

Aug. 14, 2018

OrthoTrophix presents phase II results for TPX-100 in patients with knee osteoarthritis

Aug. 14, 2018

VistaGen and Baylor College of Medicine collaborate on first-step study of AV-101

Aug. 14, 2018

First patient treated in phase Ib study of resiniferatoxin for OA knee pain

Aug. 14, 2018

Cellect signs stem cell collaboration agreement with Cell2in

Aug. 14, 2018

PIM-2 kinase suppresses T-cell responses to alloantigen and tumor cells

Aug. 14, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
Autobahn on the fast track with bipolar thyroid agonist
BioWorld
Achieving high marks in the phase II Amplify-BD trial for bipolar I and II depression, Autobahn Therapeutics Inc.’s elunetirom, a brain-penetrant central nervous...